The Indian Institute of Technology, Mandi's researchers have recognized a drug molecule that can be utilized to treat Diabetes. The molecule, named PK2, is able to activate the release of insulin by the pancreas and can possibly be used for Diabetes as oral medicine.

The research team's findings have been printed in the Journal of Biological Chemistry. The Associate Professor of the School of Basic Sciences Dr. Prosenjit Mondal authored the paper along with Prof. of School of Basic Sciences of IIT Mandi Subrata Ghosh and Dr. Sunil Kumar, ICAR- IASRI from PUSA, New Delhi. The other co-authors are Dr. Budheswar Dehury from ICMR RMRC, Bhubaneswar, Dr. Khyati Girdhar, Dr.Abhinav Choubey, Ms. Shilpa Thakur, Dr. Pankaj Gaur, Ms. Bidisha Biswas from IIT Mandi, Ms. Surbhi Dogra, and Dr.Durgesh Kumar Dwivedi from RARI, Gwalior.

Dr. Prosenjit Mondal, while explaining their research, informed that the present-day drugs such as Liraglutide and Exenatide are used for Diabetes and administered as injections. "These drugs are costly and unstable after administration. We seek to find simpler drugs that are stable, cheap, and effective against both Type 1 and Type 2 diabetes", he added.